What Nutrien (TSX:NTR)'s Upward Earnings Revisions Reveal About Analyst Confidence

• In the lead-up to Nutrien's Q3 earnings report, analysts projected a significant year-over-year increase in earnings per share and higher revenues, driven by growth in core segments such as Nitrogen, Phosphate, and Potash.
• Recent upward revisions in consensus estimates highlight rising analyst confidence in Nutrien's near-term business outlook and key operational performance.
• We'll examine how analysts' increasing optimism about revenue and earnings could shape Nutrien's investment narrative moving forward.

Find companies with promising cash flow potential yet trading below their fair value.

Nutrien Investment Narrative Recap

To own Nutrien stock, you need to believe that global demand for crop nutrients will continue to support steady sales growth and margin stability, especially as the world seeks to maximize agricultural output. The recent analyst upgrades in advance of Q3 earnings sharpen focus on rising revenues in core segments, strengthening the short-term earnings catalyst, while the company’s reliance on fertilizer prices remains the major risk; the news does not materially alter these fundamentals.

Among recent announcements, Nutrien’s reaffirmed nitrogen sales volume guidance for 2025 stands out, directly tying into analyst optimism around revenue and earnings momentum heading into the earnings release. Consistent guidance, even as Trinidad operations are shuttered, may reinforce short-term confidence but does not remove the longer-term vulnerability to shifting global fertilizer prices or regulation.

However, investors should also consider that if fertilizer prices or demand falter unexpectedly, Nutrien’s earnings could face...

Read the full narrative on Nutrien (it's free!)

Nutrien's outlook anticipates $27.5 billion in revenue and $2.3 billion in earnings by 2028. This requires 3.2% annual revenue growth and a $0.9 billion increase in earnings from the current $1.4 billion.

Uncover how Nutrien's forecasts yield a CA$87.81 fair value, a 16% upside to its current price.

Exploring Other Perspectives

Ten individual fair value estimates from the Simply Wall St Community range from CA$67 to CA$105.19 per share. While many expect long term stability in fertilizer demand as a core driver, you should be aware that reliance on key crop nutrients still exposes the company to sizeable market swings, reviewing different viewpoints can help clarify where you stand.

Explore 10 other fair value estimates on Nutrien - why the stock might be worth as much as 39% more than the current price!

Build Your Own Nutrien Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Nutrien research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Nutrien research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Nutrien's overall financial health at a glance.

Seeking Other Investments?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• These 14 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• Rare earth metals are the new gold rush. Find out which 38 stocks are leading the charge.
• Uncover the next big thing with financially sound penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com